These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24430933)

  • 21. Consensus genes of the literature to predict breast cancer recurrence.
    Lauss M; Kriegner A; Vierlinger K; Visne I; Yildiz A; Dilaveroglu E; Noehammer C
    Breast Cancer Res Treat; 2008 Jul; 110(2):235-44. PubMed ID: 17899371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
    De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
    Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer.
    Xu H; Moni MA; Liò P
    Comput Biol Chem; 2015 Dec; 59 Pt B():15-31. PubMed ID: 26611766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.
    Starmans MH; Krishnapuram B; Steck H; Horlings H; Nuyten DS; van de Vijver MJ; Seigneuric R; Buffa FM; Harris AL; Wouters BG; Lambin P
    Br J Cancer; 2008 Dec; 99(11):1884-90. PubMed ID: 18985037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical validation of a customized multiple signature microarray for breast cancer.
    Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
    Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic gene signatures for patient stratification in breast cancer: accuracy, stability and interpretability of gene selection approaches using prior knowledge on protein-protein interactions.
    Cun Y; Fröhlich HF
    BMC Bioinformatics; 2012 May; 13():69. PubMed ID: 22548963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model.
    Motakis E; Ivshina AV; Kuznetsov VA
    IEEE Eng Med Biol Mag; 2009; 28(4):58-66. PubMed ID: 19622426
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the prediction ability of survival models based on both clinical and omics data: two case studies.
    De Bin R; Sauerbrei W; Boulesteix AL
    Stat Med; 2014 Dec; 33(30):5310-29. PubMed ID: 25042390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.
    Tang ZQ; Han LY; Lin HH; Cui J; Jia J; Low BC; Li BW; Chen YZ
    Cancer Res; 2007 Oct; 67(20):9996-10003. PubMed ID: 17942933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of breast cancer.
    Cheang MC; van de Rijn M; Nielsen TO
    Annu Rev Pathol; 2008; 3():67-97. PubMed ID: 18039137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network information improves cancer outcome prediction.
    Roy J; Winter C; Isik Z; Schroeder M
    Brief Bioinform; 2014 Jul; 15(4):612-25. PubMed ID: 23255167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BLASSO: integration of biological knowledge into a regularized linear model.
    Urda D; Aragón F; Bautista R; Franco L; Veredas FJ; Claros MG; Jerez JM
    BMC Syst Biol; 2018 Nov; 12(Suppl 5):94. PubMed ID: 30458775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. netClass: an R-package for network based, integrative biomarker signature discovery.
    Cun Y; Fröhlich H
    Bioinformatics; 2014 May; 30(9):1325-6. PubMed ID: 24443376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.
    Ow GS; Kuznetsov VA
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S2. PubMed ID: 26100469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.